GS
NVS icon

GTS Securities’s Novartis NVS Stock Holding History

GTS Securities’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-81,500
Closed -$9.37M – 3156
2024
Q3 		$9.37M Buy
81,500
+47,900
+143% +$5.44M 0.02% 540
2024
Q2 		$3.58M Sell
33,600
-2,300
-6% -$231K 0.01% 1087
2024
Q1 		$3.47M Sell
35,900
-44,800
-56% -$4.59M 0.01% 1100
2023
Q4 		$8.15M Sell
80,700
-13,800
-15% -$1.33M 0.01% 713
2023
Q3 		$9.63M Buy
+94,500
New +$9.59M 0.02% 619

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GTS Securities's NVS Position: Q1 2026 in Review

GTS Securities sold out of Novartis (NVS) in Q1 2026, closing a stake of 2,018 shares — an estimated $278K sold.

GTS Securities first reported a position in NVS in Q3 2024 and held it in 6 quarters. The position peaked at $1.6M in Q3 2025. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • GTS Securities reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
  • GTS Securities sold 2,018 Novartis shares in Q1 2026, an estimated $278K.
  • GTS Securities first reported a position in Novartis in Q3 2024 and held it in 6 quarters.
  • GTS Securities's Novartis position peaked at $1.6M in Q3 2025.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.